Cataflam and Metformin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cataflam (diclofenac potassium) and Metformin (metformin hydrochloride). Common drug interactions include general physical health deterioration among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Cataflam and Metformin. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.

What is Cataflam?

Cataflam has active ingredients of diclofenac potassium. It is often used in pain. eHealthMe is studying from 1,851 Cataflam users. Check the latest studies of Cataflam.

What is Metformin?

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 465,355 Metformin users. Check the latest studies of Metformin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 23, 2026

55 people who take Cataflam and Metformin together, and have interactions are studied.

Cataflam and Metformin drug interactions.

What are the common drug interactions of Cataflam and Metformin, by gender? *:

female:

  1. General physical health deterioration (weak health status)
  2. Heart valve incompetence (heart's valves do not work correctly)
  3. Hepatic cyst
  4. Hepatic steatosis (fatty liver disease)
  5. Hyperchlorhydria (gastric acid levels are higher in stomach)
  6. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  7. Hypersensitivity
  8. Hypotension (abnormally low blood pressure)
  9. Ill-defined disorder
  10. Infection

male:

  1. Drug ineffective
  2. Fatigue (feeling of tiredness)
  3. Urinary tract infection
  4. Abdominal discomfort
  5. Activities of daily living impaired
  6. Arthralgia (joint pain)
  7. Cardiac arrest
  8. Coma (state of unconsciousness lasting more than six hours)
  9. Gait disturbance
  10. Haematemesis (vomiting of blood)

What are the common drug interactions of Cataflam and Metformin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Hepatic steatosis (fatty liver disease)
  2. Hyperhidrosis (abnormally increased sweating)
  3. Hypothalamo-pituitary disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function)
  4. Insulin-like growth factor increased
  5. Limb injury
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Nephrolithiasis (calculi in the kidneys)
  8. Road traffic accident
  9. Injection site pain
  10. Adjustment disorder with depressed mood

50-59:

  1. Diabetes mellitus inadequate control
  2. Headache (pain in head)
  3. Thyroid mass
  4. Blood glucose increased
  5. Blood pressure inadequately controlled
  6. Breast disorder female
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Lung infection
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)

60+:

  1. Haemorrhage (bleeding)
  2. International normalised ratio increased
  3. Night sweats (sweating in night)
  4. Oedema peripheral (superficial swelling)
  5. Pain in extremity
  6. Parkinson's disease
  7. Pneumonia
  8. Respiratory tract infection
  9. Therapeutic response decreased (less preventive response)
  10. Hypoglycaemia (deficiency of glucose in the bloodstream)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 15 people, 27.27%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 14.55%
  3. High Blood Pressure: 8 people, 14.55%
  4. High Blood Cholesterol: 8 people, 14.55%
  5. Thyroid Diseases: 4 people, 7.27%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 7.27%
  7. Psoriasis (immune-mediated disease that affects the skin): 3 people, 5.45%
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 5.45%
  9. Multiple Myeloma (cancer of the plasma cells): 3 people, 5.45%
  10. Inflammation: 3 people, 5.45%

* Approximation only. Some reports may have incomplete information.

Do you take Cataflam and Metformin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cataflam and Metformin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cataflam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Metformin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cataflam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metformin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on diclofenac potassium and metformin hydrochloride (the active ingredients of Cataflam and Metformin, respectively), and Cataflam and Metformin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: